REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Abidi Pharmaceuticals Company Public Joint Stock (Dr. Abidi Pharmaceutical Laboratories Company Public Shareholding Company) (Iran)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Dr. Abidi Pharmaceuticals Company Public Joint Stock Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr. Abidi Pharmaceuticals Company Public Joint Stock (Dr. Abidi Pharmaceutical Laboratories Company Public Shareholding Company) is an enterprise located in Iran, with the main office in Tehran. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on April 04, 1973. Dr. Abidi Pharmaceuticals Company Public Joint Stock (Dr. Abidi Pharmaceutical Laboratories Company Public Shareholding Company) currently employs 2,046 (2024) people. From the latest financial highlights, Dr. Abidi Pharmaceuticals Company Public Joint Stock (Dr. Abidi Pharmaceutical Laboratories Company Public Shareholding Company) reported a net sales revenue increase of 62.78% in Q3C2025. There was a total growth of 40.91% in Dr. Abidi Pharmaceuticals Company Public Joint Stock (Dr. Abidi Pharmaceutical Laboratories Company Public Shareholding Company)’s total assets over the same period. The enterprise’s net profit margin increased by 8.46% in 2025.

Headquarters
8Th Km Of Shahid Lashgari Expressway, (Karaj Makhsoos Road), Abidi Boulevard - No. 72, Po Box 13445-156
Tehran; Tehran; Postal Code: 13897-76363

Contact Details: Purchase the Dr. Abidi Pharmaceuticals Company Public Joint Stock (Dr. Abidi Pharmaceutical Laboratories Company Public Shareholding Company) report to view the information.

Website: http://www.abidipharma.com

Basic Information
Total Employees:
Purchase the Dr. Abidi Pharmaceuticals Company Public Joint Stock (Dr. Abidi Pharmaceutical Laboratories Company Public Shareholding Company) report to view the information.
Outstanding Shares:
Purchase the Dr. Abidi Pharmaceuticals Company Public Joint Stock (Dr. Abidi Pharmaceutical Laboratories Company Public Shareholding Company) report to view the information.
Financial Auditors:
Purchase the Dr. Abidi Pharmaceuticals Company Public Joint Stock (Dr. Abidi Pharmaceutical Laboratories Company Public Shareholding Company) report to view the information.
Incorporation Date:
April 04, 1973
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
66%
Purchase this report to view the information.
19%
Purchase this report to view the information.
4%
Purchase this report to view the information.
2%
Subsidiaries
Progress And Success Co., Ltd., Kausar Amin
100%
Shares Of Amin Salamat Baharan Company
100%
Behozan Pharmaceutical Company
88%
Company Performance
Financial values in the chart are available after Dr. Abidi Pharmaceuticals Company Public Joint Stock (Dr. Abidi Pharmaceutical Laboratories Company Public Shareholding Company) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
62.78%
Total Operating Revenue
63.7%
Operating Profit
78.44%
EBITDA
77.47%
Net Profit/Loss for the Period
143.92%
Total Assets
40.91%
Total Equity
56.45%
Operating Profit Margin
3.77%
Net Profit Margin
8.46%
Return on Equity (ROE)
10.45%
Debt / Equity
-25740%
Quick Ratio
305.47%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?